Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1987-07-21
1990-01-30
Sneed, H. M. S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514909, A61K 3156
Patent
active
048973904
ABSTRACT:
The present invention provides novel compounds for controlling mammalian obesity by simultaneous action upon caloric intake and caloric expenditure. This is accomplished by the administration of pharmaceutically acceptable and therapeutically active analogs of .alpha.-HET and .beta.-HET, having a methyl group at the 3.beta. position to avoid metabolically induced conjugation of the molecule to an inactive species while retaining the structural integrity of the molecule.
REFERENCES:
patent: 4137327 (1979-01-01), Marshall
patent: 4379842 (1983-04-01), Fujiwara et al.
patent: 4518595 (1985-05-01), Coleman et al.
patent: 4602008 (1986-07-01), Kresk
patent: 4657759 (1987-04-01), Hansen et al.
Kappas, A., Hellman, L., Fukushima, K., Gallagher, T. F., "The Thermogenic Effect and Metabolic Fate of Etiocholanone in Man," 18, J. Endocrin. & Metab. Oct., 1958, pp. 1043-1055.
Coleman, D. L., Leiter, E. H., Schwizer, R. W., "Therapeutic Effects of Dehydroepiandrosterone (DHEA) in Diabetic Mice", 31, Diabetes Sep. 1982, pp. 830-833.
Schwartz, A. G., Hard, G. C., Pashko, L. L., Abou-Gharbia, M., "Dehydroepiandrosterone: An Anti-Obesity and Anti-Carcinogenic Agent", 3, Nutrition and Cancer, 1983, pp. 46-52.
Yen, T. T., Allan, J. A., Pearson, D. V., Acton, J. M., Greenberg, M. M., "Prevention of Obesity in A.sup.vy /a Mice by Dehydroepiandrosterone," 12, Lipids, pp. 409-413.
Coleman, D. L., Leiter, E. H., Applezweig, N., "Therapeutic Effects of Dehydroepiandrosterone Metabolites in Diabetes Mutant Mice (C57BL/KsJ-db/db)," 115, Endocrinology, 1984, pp. 239-243.
Pashko, L. L., Hard, G. C., Rovito, R. J., Williams, J. R., Sobel, E. L. & Schwartz, A. G., "Inhibition of 7,12-dimethylbenz(a)anthracene-induced Skin Papillomas & Carcinomas by Dehydroepiandrosterone 3-beta-methyl-androst-5-en-17-one in Mice," 45, Cancer Res., pp. 164-166.
J. Am. Chem. Soc. 80: 1769-1770 (1958), Mueller G. P. et al.
Abou-Gharbia, M.; et al., J. of Pharm. Sc., vol. 70, No. 10, Oct. 87, 1154-1157 (1981).
Mueller, G., W. F. Johns, J. Org. Chem. 26: 2403-2412 (1961).
Saba James
Sneed H. M. S.
LandOfFree
Novel anti-obesity compounds and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel anti-obesity compounds and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel anti-obesity compounds and method of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1923539